Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
"Outdated policies and lack of coverage for obesity medications create an urgent need for more innovative solutions
Scientists at Monash University in Australia developed AOD 9604 in the 1990s specifically as an anti-obesity treatment
This applies to all conditions listed with diabetes in the Index (CKD, neuropathy, retinopathy, etc.)
Potential Benefits: May increase metabolic rate 1520% in cell studies Oral bioavailability being optimized Suggested Clinical Dosing Range: Conservative start: 100200 mg daily Dosing is individualized and determined by a qualified medical provider
US$ 26.99
US$ 26.15
US$ 20.56
US$ 23.33
US$ 22.63
